These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 339329)

  • 21. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Könyves I
    Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of Estracyt in cases of prostatic neoplasms].
    Wesolowski S; Czaplicki M; Cieślak A
    Pol Przegl Chir; 1976 Jun; 48(6A):783-9. PubMed ID: 951325
    [No Abstract]   [Full Text] [Related]  

  • 23. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 24. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R; Köllin CP
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate.
    Vahlensieck W; Wegner G; Lehmann HD; Franzen G; Steffens L; Wählby S
    Urol Res; 1985; 13(5):209-12. PubMed ID: 3904132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC
    Wis Med J; 1976 Sep; 75(9):S89-90. PubMed ID: 969557
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W; Wegner G
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute.
    Murphy GP; Slack NH; Mittelman A
    Urology; 1984 Jun; 23(6 Suppl):54-63. PubMed ID: 6375081
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of previous treatment on Estracyt response in advanced stage D prostatic carcinoma.
    Mittelman A
    Urology; 1984 Jun; 23(6 Suppl):78-80. PubMed ID: 6730142
    [No Abstract]   [Full Text] [Related]  

  • 34. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J; Jung JL; Bittard M
    J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA; Rosenthal H; Mittelman A; Murphy GP
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M; Lutherer S; Terhorst B
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estracyt therapy in advanced prostate cancer: current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 May; 22(3):162-6. PubMed ID: 6683899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
    Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.